Neovasc (NVCN) PT Lowered to $2 at Leerink Partners; 'Tiara Clinical Trials Continue to Progress'
Go back to Neovasc (NVCN) PT Lowered to $2 at Leerink Partners; 'Tiara Clinical Trials Continue to Progress'| (NASDAQ: NVCN) | Delayed: 30.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.03 | 52 Week High | $5.04 | |||
| Open | $30.03 | 52 Week Low | $0.37 | |||
| Day High | $30.03 | P/E | N/A | |||
| Day Low | $30.03 | EPS | $0.00 | |||
| Volume | 10,291 | |||||
